Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for Itching from Hypertrophic Scar
NCT02168634Unknown
- Sponsor
- Kaohsiung Veterans General Hospital
- Start
- Nov 2013
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of botulinum toxin type A in Hypertrophic Scar (HS) (2 arms), sponsored by Kaohsiung Veterans General Hospital. Primary endpoint: The degree of itchiness at 6 months. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on NCT02168634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02168634.